Issued Patents All Time
Showing 1–15 of 15 patents
| Patent # | Title | Co-Inventors | Date |
|---|---|---|---|
| 11590215 | Process for the production of a DNA vaccine for cancer immunotherapy | — | 2023-02-28 |
| 11357842 | PD-L1 targeting DNA vaccine for cancer immunotherapy | — | 2022-06-14 |
| 10980868 | VEGFR-2 targeting immunotherapy approach | — | 2021-04-20 |
| 10905752 | VEGFR-2 targeting DNA vaccine for combination therapy | — | 2021-02-02 |
| 10821163 | Process for the production of a DNA vaccine for cancer immunotherapy | — | 2020-11-03 |
| 10815455 | Salmonella-based vectors for cancer immunotherapy targeting Wilms' tumor gene WT1 | Marco Springer | 2020-10-27 |
| 10441645 | MSLN targeting DNA vaccine for cancer immunotherapy | Marco Springer | 2019-10-15 |
| 10293037 | DNA vaccine for use in pancreatic cancer patients | — | 2019-05-21 |
| 9920297 | Salmonella-based vectors for cancer immunotherapy targeting wilms' tumor gene WT1 | Marco Springer | 2018-03-20 |
| 9493738 | Method for producing high yield attenuated Salmonella strains | Holger Siede, Renate Janssen, Marco Springer | 2016-11-15 |
| 9468685 | Methods of preparing a liquid formulation of G-CSF | Walter Hinderer | 2016-10-18 |
| 9415098 | DNA vaccine for use in pancreatic cancer patients | — | 2016-08-16 |
| 9050304 | Methods of treatment using glycopegylated G-CSF | David A. Zopf | 2015-06-09 |
| 8946161 | Method of treatment using stable liquid formulation of G-CSF | Walter Hinderer | 2015-02-03 |
| 8562967 | Stable liquid formulations of G-CSF | Walter Hinderer | 2013-10-22 |